TY - JOUR
T1 - Altered red cell osmotic fragility in Huntington disease (HD)
AU - McCormack, M. K.
AU - Ullman, J.
AU - Lazzarini, A.
PY - 1982
Y1 - 1982
N2 - The authors have studied in fresh and 24-hour incubated samples the osmotic fragility of erythrocytes from 13 individuals with Huntington disease (HD) and 22 at-risk, asymptomatic individuals. Five older at-risk, asymptomatic individuals and six Alzheimer disease individuals were also studied. Results suggest that osmotic fragility of red cells from HD individuals is significantly decreased in fresh (P <0.0001) and incubated (P <0.001) samples. At-risk individuals appear to fall into two groups: 1) those with normal osmotic fragility (n = 10), and 2) those with decreased osmotic fragility (n = 12). Fragility in older at-risk persons and those with Alzheimer disease were within normal limits. These data suggest that red cell osmotic fragility measurement may be useful to identify at-risk persons with an HD gene; however, longitudinal follow-up will be required to confirm the predictive power of this observation. These data suggest additional support for focusing on the erythrocyte in investigating the molecular pathogenesis of HD.
AB - The authors have studied in fresh and 24-hour incubated samples the osmotic fragility of erythrocytes from 13 individuals with Huntington disease (HD) and 22 at-risk, asymptomatic individuals. Five older at-risk, asymptomatic individuals and six Alzheimer disease individuals were also studied. Results suggest that osmotic fragility of red cells from HD individuals is significantly decreased in fresh (P <0.0001) and incubated (P <0.001) samples. At-risk individuals appear to fall into two groups: 1) those with normal osmotic fragility (n = 10), and 2) those with decreased osmotic fragility (n = 12). Fragility in older at-risk persons and those with Alzheimer disease were within normal limits. These data suggest that red cell osmotic fragility measurement may be useful to identify at-risk persons with an HD gene; however, longitudinal follow-up will be required to confirm the predictive power of this observation. These data suggest additional support for focusing on the erythrocyte in investigating the molecular pathogenesis of HD.
UR - http://www.scopus.com/inward/record.url?scp=0020041557&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020041557&partnerID=8YFLogxK
U2 - 10.1002/ajmg.1320110108
DO - 10.1002/ajmg.1320110108
M3 - Article
C2 - 6461249
AN - SCOPUS:0020041557
SN - 0148-7299
VL - 11
SP - 53
EP - 59
JO - American Journal of Medical Genetics
JF - American Journal of Medical Genetics
IS - 1
ER -